3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
74
Observational
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Uterine Cervical Dysplasia
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
1
Interventions
atezolizumab
5
durvalumab
4
Drug Therapy
4
Carboplatin
4
Psychiatric Rehabilitation
3
Immunotherapy
3
Topotecan
2
Specimen Handling
2
Radiotherapy
2
Polymerase Chain Reaction
2
PM 01183
2
Observation
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Immune Checkpoint Inhibitors
2
Ifosfamide
2
Etoposide
2
Cisplatin
2
Biopsy
2
trastuzumab deruxtecan
1
nedaplatin
1
X-Ray Therapy
1
Watchful Waiting
1
Vinorelbine
1
Tomography, Optical Coherence
1
Tissue Banks
1
Therapeutics
1
Radiation, Ionizing
1
Phlebotomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Small Cell Lung Carcinoma
×
Topotecan
×
Clear all
NCT01037023
2015-04-15
Hycamtin PMS
GlaxoSmithKline
Completed
92 enrolled
NCT00997061
2014-02-03
SCOT
GlaxoSmithKline
Completed
500 enrolled